Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have long-term heart failure where the heart's main pumping chamber is not squeezing properly (known as systolic heart failure)
- People whose heart's pumping strength (called ejection fraction) is 35% or lower
- People whose doctors have recommended a specific heart device called cardiac resynchronisation therapy (CRT) based on standard medical guidelines, at either a Class I or Class II level of recommendation (confirm with trial site)
Who may not be able to join:
- People who are unable to give their own informed consent to participate
- People who are pregnant
- People who have metal fragments in their body from a past accident or injury, confirmed by X-ray or other imaging
- People who have surgical clips in the brain used to treat a burst blood vessel (cerebral aneurysm)
- People who have a cochlear implant (a hearing device implanted in the ear)
- People who have other metal implants that are known to be unsafe during a heart MRI scan — note that pacemakers and ICDs (implanted heart devices) are not automatically excluded under this criterion (confirm with trial site)
- People who experience severe claustrophobia (extreme fear of enclosed spaces, such as an MRI machine)
- People who have sudden, recent kidney damage (acute kidney injury)
- People who have sudden kidney failure or long-term kidney disease where the kidneys are not filtering blood well enough (a specific filtering rate below 45 cc/min/1.73m²)
- People who have had a liver transplant
- People who have a known allergy to gadolinium (a contrast dye used in MRI scans)
- People whose hearts show more than 10% of beats as irregular extra heartbeats from the lower chambers (premature ventricular contractions)
- People whose available health records suggest they are in an irregular heart rhythm called atrial fibrillation more than 10% of the time
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kenneth C Bilchick, MD, University of Virginia Health System
Phone: 4349242465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Left ventricular end-systolic volume (LVESV) improvement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.